358 related articles for article (PubMed ID: 16842377)
1. The role of pharmacogenetics in cancer therapeutics.
Yong WP; Innocenti F; Ratain MJ
Br J Clin Pharmacol; 2006 Jul; 62(1):35-46. PubMed ID: 16842377
[TBL] [Abstract][Full Text] [Related]
2. [Value and applications of pharmacogenetics in oncology and hematology].
Albin N; Massade L; Gouyette A
Bull Cancer; 1997 Jun; 84(6):643-51. PubMed ID: 9295869
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
Yan L; Beckman RA
Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of cytotoxic drugs.
Daly AK; Hall AG
Expert Rev Anticancer Ther; 2001 Aug; 1(2):301-8. PubMed ID: 12113035
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacogenetics of anticancer drugs].
de Chaisemartin L; Loriot MA
Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
[TBL] [Abstract][Full Text] [Related]
6. Part 3: Pharmacogenetic variability in phase II anticancer drug metabolism.
Deenen MJ; Cats A; Beijnen JH; Schellens JH
Oncologist; 2011; 16(7):992-1005. PubMed ID: 21659608
[TBL] [Abstract][Full Text] [Related]
7. Cancer pharmacogenomics: achievements in basic research.
Nakajima M; Yokoi T
Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacogenetics in oncology: the paradigm of molecular targeted therapies.
Mountzios G; Sanoudou D; Syrigos KN
Curr Pharm Des; 2010; 16(20):2184-93. PubMed ID: 20459386
[TBL] [Abstract][Full Text] [Related]
9. Germline genetic testing to predict drug response and toxicity in oncology--reality or fiction?
Soh TI; Yong WP
Ann Acad Med Singap; 2011 Aug; 40(8):350-5. PubMed ID: 22065000
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics in cancer treatment.
Nagasubramanian R; Innocenti F; Ratain MJ
Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics: road to anticancer therapeutics nirvana?
Desai AA; Innocenti F; Ratain MJ
Oncogene; 2003 Sep; 22(42):6621-8. PubMed ID: 14528287
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics and pharmacogenomics of anticancer agents.
Huang RS; Ratain MJ
CA Cancer J Clin; 2009; 59(1):42-55. PubMed ID: 19147868
[TBL] [Abstract][Full Text] [Related]
13. Effect of pharmacogenetics on medicine.
Weber WW
Environ Mol Mutagen; 2001; 37(3):179-84. PubMed ID: 11317335
[TBL] [Abstract][Full Text] [Related]
14. Cancer pharmacogenetics.
Marsh S
Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
[TBL] [Abstract][Full Text] [Related]
15. Clinically relevant cancer biomarkers and pharmacogenetic assays.
Patel JN; Mandock K; McLeod HL
J Oncol Pharm Pract; 2014 Feb; 20(1):65-72. PubMed ID: 23353710
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics and cancer chemotherapy.
Iyer L; Ratain MJ
Eur J Cancer; 1998 Sep; 34(10):1493-9. PubMed ID: 9893619
[TBL] [Abstract][Full Text] [Related]
17. Cancer pharmacogenomics: strategies and challenges.
Wheeler HE; Maitland ML; Dolan ME; Cox NJ; Ratain MJ
Nat Rev Genet; 2013 Jan; 14(1):23-34. PubMed ID: 23183705
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics and pediatric cancer.
Bomgaars L; McLeod HL
Cancer J; 2005; 11(4):314-23. PubMed ID: 16197721
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics in cancer therapy: is host genome variability important?
Petros WP; Evans WE
Trends Pharmacol Sci; 2004 Sep; 25(9):457-64. PubMed ID: 15559247
[TBL] [Abstract][Full Text] [Related]
20. Somatic pharmacogenomics in cancer.
Ikediobi ON
Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
